Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

D-cycloserine reduces cocaine-seeking behavior in 'addicted' mice

07.11.2007
Antibiotic that appears to control phobias may also be useful in treating addiction

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory provide further evidence that a drug known as D-cycloserine could play a role in helping to extinguish the craving behaviors associated with drug addiction. Their study found that mice treated with D-cycloserine were less likely to spend time in an environment where they had previously been trained to expect cocaine than mice treated with a placebo.

"Since the association between drugs and the places where they are used can trigger craving and/or relapse in humans, a medication that could aid in the reduction or even extinction of such responses could be a powerful tool in the treatment of addiction," said Carlos Bermeo, a Stony Brook University graduate student working under the direction of Brookhaven Lab neuroscientist Panayotis (Peter) Thanos. Bermeo will present these results in a talk at the Society for Neuroscience annual meeting in San Diego on Tuesday, November 6, 2007, at 11 a.m.

D-cycloserine was originally developed as an antibiotic. But it has also been shown to extinguish conditioned fear in pre-clinical (animal) studies, and has been successfully tested in human clinical trials for the treatment of acrophobia (fear of heights). This finding led several researchers to wonder whether D-cycloserine could extinguish drug-seeking behaviors as well.

In 2006, a group of scientists not affiliated with Brookhaven Lab tested this hypothesis in rats. They found that D-cycloserine facilitated the extinction of "cocaine conditioned place preference" - the tendency for the animals to spend more time in a chamber where they had been trained to expect cocaine than in a chamber where they had no access to the drug.

The Brookhaven study builds on the previous work and adds information on the drug dose effect, the lasting properties of the treatment, and the locomotor effects of this compound.

Bermeo and Thanos' group worked with C57bL/c mice. Animals were first trained to receive cocaine in a particular environment. Once conditioned place preference was established (that is, animals willingly spent more time in a cocaine-paired environment than in a "neutral" environment), the mice were treated with either D-cycloserine or saline and allowed to spend forty minutes in either the previously cocaine-paired environment (with the drug no longer available) or the neutral environment.

"This paradigm would be analogous to a clinical approach where the addict is returned to the environment that previously was the place of drug use (e.g., the neighborhood or home), but this time with no drug available," said Thanos. "Reduced seeking of the drug in the same environment - that is extinction behavior - is a great indicator of future success in treatment and reduced chance of relapse," he added.

Mice treated with D-cycloserine showed less preference for the cocaine-paired environment and did this more rapidly than mice treated with saline. The low dose (15 milligrams D-cycloserine per kilogram of body weight, given intraperitonially) showed a 10 percent decrease in time spent in the previously cocaine-paired environment, and the high dose (30 mg/kg i.p.) showed a 17 percent decrease in the time spent in the previously cocaine-paired environment. The high dose produced a more pronounced and consistent extinction than the lower dose.

Interestingly, animals treated with the high dose of D-cycloserine exhibited lower locomotor activity compared to both the low-dose D-cycloserine group and the saline-treated animals. These two groups exhibited similar levels of locomotor activity. This indicates that dosing may have to be fine tuned to achieve optimal efficacy with minimum side effects.

"It's important to remember that these are very preliminary results from a small animal study," Thanos cautions. "Much further research will be required before testing this drug in humans. But it is inspiring to know that this drug may show promise in treating cocaine addiction, which continues to take a toll on society and for which no pharmacological treatment currently exists."

Karen McNulty Walsh | EurekAlert!
Further information:
http://www.bnl.gov

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>